Targovax ASA (GB:0RIS) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Circio Holding ASA has increased its share capital following the conversion of convertible bonds, positioning itself as a leader in circular RNA gene therapies. The company’s innovative circVec platform enhances protein expression, potentially setting a new standard for DNA and virus-based therapeutics. Additionally, Circio is advancing its cancer vaccine, TG01, in clinical trials across the USA and Norway, backed by significant research grants.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
